NCT07129252
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07129252
Title A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors (BRAVESST2)
Acronym BRAVESST2
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Crinetics Pharmaceuticals Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Crinetics Study Site Phoenix Arizona 85054 United States Details
Crinetics Study Site Duarte California 91010 United States Details
Crinetics Study Site Newport Beach California 92663 United States Details
Crinetics Study Site Orange California 92868 United States Details
Crinetics Study Site San Francisco California 60637 United States Details
Crinetics Study Site Aurora Colorado 80045 United States Details
Crinetics Study Site Denver Colorado 80218 United States Details
Crinetics Study Site New Haven Connecticut 48201 United States Details
Crinetics Study Site Atlanta Georgia 30322 United States Details
Crinetics Study Site Lexington Kentucky 40536 United States Details
Crinetics Study Site Metairie Louisiana 70006 United States Details
Crinetics Study Site Detroit Michigan 48201 United States Details
Crinetics Study Site Grand Rapids Michigan 49503 United States Details
Crinetics Study Site Rochester Minnesota 53905 United States Details
Crinetics Study Site New York New York 10016 United States Details
Crinetics Study Site Philadelphia Pennsylvania 19104 United States Details
Crinetics Study Site Philadelphia Pennsylvania 19111 United States Details
Crinetics Study Site Austin Texas 78758 United States Details
Crinetics Study Site Houston Texas 70030 United States Details
Crinetics Study Site Irving Texas 75039 United States Details
Crinetics Study Site Salt Lake City Utah 84112 United States Details
Crinetics Study Site Charlottesville Virginia 22908 United States Details
Crinetics Study Site Fairfax Virginia 22031 United States Details
Crinetics Study Site Barcelona 08023 Spain Details
Crinetics Study Site Barcelona 08035 Spain Details
Crinetics Study Site Madrid 28040 Spain Details
Crinetics Study Site Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field